Navigation Links
The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases

PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and Merieux Alliance have signed a letter of intent for a long-term research partnership.

The Institut Pasteur and Merieux Alliance (which comprises the companies: bioMerieux, Transgene, Shantha Biotechnics, ABL and Silliker) would like to pool their resources and efforts to fight infectious diseases through major research projects, spanning the following fields:

    - Clinical diagnostics and theranostics (in partnership with
      bioMerieux and Transgene)

    - Food safety and microbiological control, nutrition, health
      and environment (with bioMerieux and Silliker)

    - Immunotherapy (with Transgene and Shantha Biotechnics)

The research projects under consideration must focus on major pathologies calling upon expertise in the fields of virology, bacteriology and immunology. The results of these joint research projects could be utilized by the Merieux Alliance companies and would enhance the Institut Pasteur's patent portfolio, contributing to the valorization of its research efforts.

This collaboration between a world-renowned scientific foundation and a major bioindustrial group exemplifies the cross-disciplinary approach needed to develop new solutions for fighting infectious diseases. It also represents a new and significant milestone in the collaboration between the Institut Pasteur and a group sharing Pasteurian roots, dedicated to biology and serving public health worldwide.

The signature of this letter of intent follows an agreement signed between the Institut Pasteur and the Fondation Merieux on April 14th, aimed at encouraging collaboration in the fight against infectious diseases in developing countries. This includes research to develop solutions adapted to local constraints, interactions between the international network of Pasteur institutes and the Fondation Merieux's GABRIEL network and the coordination of actions in the field.

"I am extremely pleased with this agreement with Merieux Alliance that will contribute to improving public health worldwide," stated Alice Dautry, president of the Institut Pasteur. "Together, we want to develop innovative approaches that will allow us, in the future, to win new battles against disease."

"I am happy to reinforce our innovation capabilities for major public health issues through this agreement," declared Alain Merieux, president of Merieux Alliance. "Reconnecting with a long, Pasteurian family legacy, I am certain that our work together will open new horizons for tomorrow's medicine."

About Institut Pasteur

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of diseases through biological research, education and public-health activities. Close to 2,600 people work on its campus in Paris, where a large part of its research activities are devoted to infectious diseases and 10% focuses on AIDS research. The Paris institute is the heart of an International Network made up that unites 30 institutes across all five continents. Over a period of 120 years, 10 Institut Pasteur researchers have received the Nobel Prize, the latest of these in 2008, when it was awarded to Professors Francoise Barre-Sinoussi and Luc Montagnier for the discovery of the Aids virus.

About Merieux Alliance

Drawing on a long tradition and renowned expertise in bioindustry, Merieux Alliance, the family holding company of Alain Merieux, is dedicated to constantly improving patient care worldwide by developing new biotechnology-based solutions.

Merieux Alliance comprises five companies dedicated to public health that span the full range of healthcare: prevention, diagnosis, prognosis, treatment and clinical follow-up:

    - bioMerieux, based in Marcy l'Etoile (France), which is 59%-controlled.
      A worldwide group specialized in the field of in vitro diagnostics and
      industrial microbiological testing;

    - Silliker, based in Chicago (US), which is 89%-controlled. A network of
      food testing and consulting laboratories;

    - Shantha Biotechnics Ltd, based in Hyderabad (India), which is
      80%-controlled. Specialized in developing and producing vaccines and
      therapeutic proteins;

    - Transgene, based in Strasbourg (France), which is 55%-controlled.
      Dedicated to the development of therapeutic vaccines and
      immunotherapeutic products in oncology and infectious diseases;

    - ABL Inc (Advanced BioScience Laboratories), based in Washington D.C.
     (US), which is 100%-owned. Specialized in virological research.

Under the leadership of Alain Merieux, 10,000 people worldwide are part of Merieux Alliance. The group achieved consolidated revenues of EUR1.3 billion in 2008.

SOURCE The Institut Pasteur and Merieux Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
2. Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
3. ALS Therapy Development Institute, the Worlds Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
4. NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer
5. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
6. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
7. Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
8. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
9. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
10. Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
11. MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... • Jeon Jin Bio ... porcine and rodent control solutions , Bird ... oil, works across all sensory modalities including visual, smell, taste and touch, enabling safe, ...
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/25/2015)... --> ... 2020 report analyzes that automating biobanking workflow will ... long-term samples, minimizing manual errors, improving the workflow ... errors such as mislabeling or inaccurate sample barcoding ... a vital role in blood fractionation, DNA extraction, ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
Breaking Biology Technology:
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):